ORIC Pharmaceuticals, Inc.
NASDAQ:ORIC
10.26 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 23.384 | 66.84 | 226.006 | 78.446 | 89.159 | 42.636 | 25.819 |
| Short Term Investments
| 184.803 | 139.432 | 10.973 | 215.154 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 208.187 | 206.272 | 236.979 | 293.6 | 89.159 | 42.636 | 25.819 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 4.41 | 4.185 | 3.543 | 3.097 | 0.84 | 1.088 | 0.791 |
| Total Current Assets
| 212.597 | 210.457 | 240.522 | 296.697 | 89.999 | 43.724 | 26.61 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 12.006 | 3.253 | 2.413 | 1.981 | 2.241 | 2.514 | 2.902 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | -3.181 | -3.414 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 27.343 | 21.951 | 43.386 | 0 | 0 | 0 | 0 |
| Tax Assets
| 2.679 | 3.181 | 3.414 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.061 | 11.517 | 12.321 | 0.319 | 1.853 | 0.496 | 0.513 |
| Total Non-Current Assets
| 42.089 | 36.721 | 58.12 | 2.3 | 4.094 | 3.01 | 3.415 |
| Total Assets
| 254.686 | 247.178 | 298.642 | 298.997 | 94.093 | 46.734 | 30.025 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 0.944 | 1.32 | 1.886 | 0.757 | 0.152 | 0.446 | 0.94 |
| Short Term Debt
| 2.752 | 2.659 | 1.926 | -0.546 | -0.495 | -0.438 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0.546 | 0.495 | 0.438 | 0.388 |
| Other Current Liabilities
| 16.762 | 11.409 | 11.339 | 8.245 | 5.202 | 2.15 | 1.282 |
| Total Current Liabilities
| 20.458 | 15.388 | 15.151 | 9.002 | 5.354 | 2.596 | 2.61 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 0.007 | 0.009 | 0.011 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| -0.007 | -0.009 | -0.011 | 0 | 0.765 | 1.251 | 1.689 |
| Deferred Tax Liabilities Non-Current
| 2.679 | 3.181 | 3.414 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 7.461 | 6.258 | 7.101 | 0.219 | 0 | 107.313 | 0 |
| Total Non-Current Liabilities
| 10.14 | 9.439 | 10.515 | 0.219 | 0.765 | 108.564 | 1.689 |
| Total Liabilities
| 30.598 | 24.827 | 25.666 | 9.221 | 6.119 | 111.16 | 4.299 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 298.997 | 178.058 | 107.266 | 69.337 |
| Common Stock
| 0.006 | 0.005 | 0.004 | 0.004 | 0.002 | 0.001 | 0.001 |
| Retained Earnings
| -434.927 | -334.23 | -245.108 | -166.393 | -92.69 | -65.807 | -44.444 |
| Accumulated Other Comprehensive Income/Loss
| 0.258 | -1.291 | -0.103 | -0.031 | -178.058 | -2.578 | 0 |
| Other Total Stockholders Equity
| 658.751 | 557.867 | 518.183 | 157.199 | 180.662 | -103.308 | 0.832 |
| Total Shareholders Equity
| 224.088 | 222.351 | 272.976 | 289.776 | 87.974 | -64.426 | 25.726 |
| Total Equity
| 224.088 | 222.351 | 272.976 | 289.776 | 87.974 | -64.426 | 25.726 |
| Total Liabilities & Shareholders Equity
| 254.686 | 247.178 | 298.642 | 298.997 | 94.093 | 46.734 | 30.025 |